List of Tables
Table 1. Global Anti-Parkinson Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Dopaminergic
Table 3. Key Players of Dopamine Agonists
Table 4. Key Players of Enzyme Inhibitors
Table 5. Key Players of Others
Table 6. Global Anti-Parkinson Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Anti-Parkinson Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Anti-Parkinson Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Anti-Parkinson Drugs Market Share by Region (2019-2024)
Table 10. Global Anti-Parkinson Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Anti-Parkinson Drugs Market Share by Region (2025-2030)
Table 12. Anti-Parkinson Drugs Market Trends
Table 13. Anti-Parkinson Drugs Market Drivers
Table 14. Anti-Parkinson Drugs Market Challenges
Table 15. Anti-Parkinson Drugs Market Restraints
Table 16. Global Anti-Parkinson Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Anti-Parkinson Drugs Market Share by Players (2019-2024)
Table 18. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Parkinson Drugs as of 2023)
Table 19. Ranking of Global Top Anti-Parkinson Drugs Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Anti-Parkinson Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anti-Parkinson Drugs Product Solution and Service
Table 23. Date of Enter into Anti-Parkinson Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-Parkinson Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Anti-Parkinson Drugs Revenue Market Share by Type (2019-2024)
Table 27. Global Anti-Parkinson Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Anti-Parkinson Drugs Revenue Market Share by Type (2025-2030)
Table 29. Global Anti-Parkinson Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Anti-Parkinson Drugs Revenue Market Share by Application (2019-2024)
Table 31. Global Anti-Parkinson Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Anti-Parkinson Drugs Revenue Market Share by Application (2025-2030)
Table 33. North America Anti-Parkinson Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Anti-Parkinson Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Anti-Parkinson Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Anti-Parkinson Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Anti-Parkinson Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Anti-Parkinson Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Anti-Parkinson Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Anti-Parkinson Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Anti-Parkinson Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Anti-Parkinson Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Parkinson Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-Parkinson Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Anti-Parkinson Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Anti-Parkinson Drugs Product
Table 51. AbbVie Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Mylan Laboratories Company Detail
Table 54. Mylan Laboratories Business Overview
Table 55. Mylan Laboratories Anti-Parkinson Drugs Product
Table 56. Mylan Laboratories Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 57. Mylan Laboratories Recent Development
Table 58. Valeant Pharmaceuticals Company Detail
Table 59. Valeant Pharmaceuticals Business Overview
Table 60. Valeant Pharmaceuticals Anti-Parkinson Drugs Product
Table 61. Valeant Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 62. Valeant Pharmaceuticals Recent Development
Table 63. Novartis Company Detail
Table 64. Novartis Business Overview
Table 65. Novartis Anti-Parkinson Drugs Product
Table 66. Novartis Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. GlaxoSmithKline Company Detail
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Anti-Parkinson Drugs Product
Table 71. GlaxoSmithKline Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Zambon Pharmaceuticals Company Detail
Table 74. Zambon Pharmaceuticals Business Overview
Table 75. Zambon Pharmaceuticals Anti-Parkinson Drugs Product
Table 76. Zambon Pharmaceuticals Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 77. Zambon Pharmaceuticals Recent Development
Table 78. Pfizer, Inc. Company Detail
Table 79. Pfizer, Inc. Business Overview
Table 80. Pfizer, Inc. Anti-Parkinson Drugs Product
Table 81. Pfizer, Inc. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 82. Pfizer, Inc. Recent Development
Table 83. Hoffmann-La Roche Company Detail
Table 84. Hoffmann-La Roche Business Overview
Table 85. Hoffmann-La Roche Anti-Parkinson Drugs Product
Table 86. Hoffmann-La Roche Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 87. Hoffmann-La Roche Recent Development
Table 88. Merck & Co. Company Detail
Table 89. Merck & Co. Business Overview
Table 90. Merck & Co. Anti-Parkinson Drugs Product
Table 91. Merck & Co. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 92. Merck & Co. Recent Development
Table 93. Orion Pharma Company Detail
Table 94. Orion Pharma Business Overview
Table 95. Orion Pharma Anti-Parkinson Drugs Product
Table 96. Orion Pharma Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 97. Orion Pharma Recent Development
Table 98. UCB Company Detail
Table 99. UCB Business Overview
Table 100. UCB Anti-Parkinson Drugs Product
Table 101. UCB Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 102. UCB Recent Development
Table 103. Teva Pharmaceutical Industries Ltd. Company Detail
Table 104. Teva Pharmaceutical Industries Ltd. Business Overview
Table 105. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product
Table 106. Teva Pharmaceutical Industries Ltd. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 107. Teva Pharmaceutical Industries Ltd. Recent Development
Table 108. Vertical Pharmaceuticals, LLC Company Detail
Table 109. Vertical Pharmaceuticals, LLC Business Overview
Table 110. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product
Table 111. Vertical Pharmaceuticals, LLC Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 112. Vertical Pharmaceuticals, LLC Recent Development
Table 113. ACADIA Pharmaceuticals Inc. Company Detail
Table 114. ACADIA Pharmaceuticals Inc. Business Overview
Table 115. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product
Table 116. ACADIA Pharmaceuticals Inc. Revenue in Anti-Parkinson Drugs Business (2019-2024) & (US$ Million)
Table 117. ACADIA Pharmaceuticals Inc. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Parkinson Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anti-Parkinson Drugs Market Share by Type: 2023 VS 2030
Figure 3. Dopaminergic Features
Figure 4. Dopamine Agonists Features
Figure 5. Enzyme Inhibitors Features
Figure 6. Others Features
Figure 7. Global Anti-Parkinson Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Anti-Parkinson Drugs Market Share by Application: 2023 VS 2030
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Online Stores Case Studies
Figure 12. Anti-Parkinson Drugs Report Years Considered
Figure 13. Global Anti-Parkinson Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Anti-Parkinson Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Anti-Parkinson Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Anti-Parkinson Drugs Market Share by Players in 2023
Figure 17. Global Top Anti-Parkinson Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Parkinson Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2023
Figure 19. North America Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Anti-Parkinson Drugs Market Share by Country (2019-2030)
Figure 21. United States Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Anti-Parkinson Drugs Market Share by Country (2019-2030)
Figure 25. Germany Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Anti-Parkinson Drugs Market Share by Region (2019-2030)
Figure 33. China Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Anti-Parkinson Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Anti-Parkinson Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Anti-Parkinson Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 48. Mylan Laboratories Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 49. Valeant Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 52. Zambon Pharmaceuticals Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 53. Pfizer, Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 54. Hoffmann-La Roche Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 55. Merck & Co. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 56. Orion Pharma Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 57. UCB Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 58. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 59. Vertical Pharmaceuticals, LLC Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 60. ACADIA Pharmaceuticals Inc. Revenue Growth Rate in Anti-Parkinson Drugs Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed